Radiotherapy modulates the host immune system in various ways such as an upregulation of MHC (major histocompatibility complex) class I molecules enhancing local CD8+ T-cell effects, intensified expression of calreticulin and other prophagocytic signals and upregulation of PD-L1 on the tumor cells surface [10]. The gene discussed is CD274; the disease is neoplasm.